G 0522 G 0522 (Fenofibrate (Micronized) 134 mg)
Pill with imprint G 0522 G 0522 is White, Capsule-shape and has been identified as Fenofibrate (Micronized) 134 mg. It is supplied by Global Pharmaceuticals.
Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 134 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for G 0522 G 0522
- G 0522 G 0522
- 134 mg
- 19.00 mm
- Prescription only
- Drug Class
- Fibric acid derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Global Pharmaceuticals
- Inactive Ingredients
croscarmellose sodium, hypromellose 2910 (6 mPa.s), magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate, gelatin, titanium dioxide, shellac, ferrosoferric oxide, propylene glycol, FD&C Blue No. 2, FD&C Red No. 40, D&C Yellow No. 10, aluminum oxide, FD&C Blue No. 1
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|68084-0835||Amerisource Health Services|
|54868-5994||Physicians Total Care Inc. (repackager)|
Related Images for "G 0522 G 0522"
More about fenofibrate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 57 Reviews
- Drug class: fibric acid derivatives
- Fenofibrate (Advanced Reading)
- Fenofibrate and Derivatives Tablets
- Fenofibrate and Derivatives Capsules
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.